#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Candida infection Anti-neutrophil cytoplasmic antibody positive vasculitis Oesophageal adenocarcinoma stage III Myotonia Myeloid leukaemia Glomerulonephritis acute Malformation venous Arterial disorder Stress cardiomyopathy B-cell lymphoma refractory Extra-osseous Ewing's sarcoma metastatic Hepatocellular carcinoma Uveal melanoma Albright's disease Cystic fibrosis respiratory infection suppression More trials…

    Learn about Rare Diseases

    Kearns-Sayre syndrome Paroxysmal nocturnal haemoglobinuria – Diagnostics Medulloblastoma – Trials in Disease Gastrointestinal stromal tumour – Basic Information Propionic acidaemia Mucopolysaccharidosis I – Trials in Disease Ornithine transcarbamoylase deficiency – Life with Disease Retinitis pigmentosa – Life with Disease Ehlers-Danlos syndrome – Life with Disease Leukoencephalopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olaptesed Pegol Diacerein Tovorafenib Teverelix Topiramate Alpha-Tocopherol Bms-986435 Db-Oto-3 LTG-001 Benzylpenicillin Sodium Azd5492 Abc-24F-116 Phenylalanine Eye103 Mps-200 Savolitinib Ttx-030 Placebo Belinostat Relacorilant More therapies…

    Learn about Your Condition

    Papilloma viral infection Irritable bowel syndrome Gouty arthritis B-cell type acute leukaemia Syphilis Proteus syndrome Hypopituitarism Plasma cell myeloma refractory Adenocarcinoma gastric Acute coronary syndrome Metastatic malignant melanoma Vasospasm Altered state of consciousness Chronic lymphocytic leukaemia Neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Squamous cell carcinoma of the oral cavity

  • Study of carboplatin, paclitaxel, and tislelizumab treatment in patients with resectable locally advanced oral cavity squamous cell carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of the oral cavity
    Investigated Drugs:
    • Tislelizumab
    • Carboplatin
    • Paclitaxel
    Italy

  • Study on Pembrolizumab and Drug Combination for Patients with Recurrent Head and Neck Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oropharyngeal cancer recurrent
    • Squamous cell carcinoma of the oral cavity
    • Laryngeal squamous cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Fluorouracil
    Germany

  • Study on the Safety and Effectiveness of Afatinib for Fanconi Anemia Patients with Advanced Squamous Cell Carcinoma in the Oral Cavity, Oropharynx, Hypopharynx, or Larynx

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital aplastic anaemia
    • Oropharyngeal squamous cell carcinoma
    • Squamous cell carcinoma of the oral cavity
    Investigated Drugs:
    • Afatinib
    Germany Spain

  • Study of neoadjuvant intratumoral ipilimumab combined with systemic nivolumab in patients with locally advanced resectable oral cavity squamous cell carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lip and/or oral cavity cancer
    • Squamous cell carcinoma of the oral cavity
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    The Netherlands

  • Study on Detecting Sentinel Lymph Nodes in Early Oral Cancer Using Gallium-68-Tilmanocept and Technetium-99m in Patients with Oral Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of the oral cavity
    Investigated Drugs:
    • Technetium (99Mtc)
    • Tilmanocept
    • Gallium (68Ga) Chloride
    The Netherlands

  • Study of low-dose radiation therapy combined with paclitaxel and carboplatin in patients with advanced throat and larynx cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    Poland
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!